Research - We are Hope > Meet Our Expert: Josep Dalmau, MD, PhD

Meet Our Expert: Josep Dalmau, MD, PhD

Faculty Title
Professor of Neurology

Administrative Title
Director, Laboratory Neuro-Oncology, University of Pennsylvania, Philadelphia, PA

Department

Research Expertise

Paraneoplastic neurologic disorders are caused by cancer-induced immunologic mechanisms. These disorders can affect any part of the central and peripheral nervous system. As a result of these immune responses, patients develop severe neurologic symptoms, including seizures, memory problems, hypothalamic dysfunction, and paralysis or sensory deficits that usually precede the diagnosis of the cancer. The current concept is that the expression of neuronal proteins by the cancer triggers an immune response against the tumor that is misdirected against the nervous system, resulting in the paraneoplastic disorder. This immune response is characterized by high titer of serum antibodies (often accompanied by cytotoxic T-cell responses) that specifically react with proteins exclusively expressed by neurons and the cancer cells (onconeuronal antigens). Detection of these serum antibodies allows the diagnosis of the neurologic disorder as paraneoplastic, saving the patient from extensive and sometimes invasive tests, and directs the search of the tumor to a few organs, depending of the type of antibody. Studies have resulted in the clinical characterization of several paraneoplastic disorders, and in discovery of a number of antibodies and target antigens, which are currently used as diagnostic tests for these syndromes. Paraneoplastic neurologic disorders are also important because they are natural models of effective anti-tumor immunity. The cancers of patients with some paraneoplastic neurologic syndromes are usually small and often escape detection by standard tests. We have demonstrated that the paraneoplastic immune response contributes to the less aggressive behavior of cancers associated to paraneoplastic syndromes. Current projects are directed to model the anti-tumor immune response in animals in order to develop novel strategies for cancer therapy.

Cancer Program
Brain and Spinal Cord Tumors
» Neuro-Oncology

Other Affiliations
American Neurological Association
American Society of Clinical Oncology (ASCO)
American Academy of Neurology
American Association for Cancer Research
Society of Neuro-oncology
Spanish Society of Neurology
Catalan Society of Neurology
European Neurological Society

Residency
University Hospital de la Sta. Cruz y San Pablo, Barcelona, Spain

Fellowship
Medical Oncology, Memorial Hospital for Cancer and Allied Diseases, New York, NY
Neurology, New York Hospital, Cornell University, New York, NY

Board Certifications
Medicine and Surgery, Spain, l978
Educational Commission for Foreign Medical Graduates (ECFMG), 1986
Federal Licensing Examination (FLEX), 1992

Honors and Awards

Residents' Award for Excellence in Teaching, Department of Neurology, University of Pennsylvania, 2005
European Neurological Society Award, 1998

Publications
Click here to see my publications

Contact Information

Researcher/Clinician:
Josep Dalmau, MD, PhD
3 W. Gates
University of Pennsylvania
3400 Spruce Street
Philadelphia, PA 19104
Office Phone: (215) 746-4707
Fax: (215) 746-4717

Assistant:
Sophia Pappas
Office Phone: 215-746-4707
Appointment Phone: 215-746-4707
Fax: 215-746-4717
sophia.pappas@uphs.upenn.edu

Home | Contact Us | Sitemap | Privacy Statement | Legal Disclaimer | Terms of Use
Trustees of the University of Pennsylvania